A physician’s perspective on applying for an IDE, interaction with the FDA, and practice under an IDE.
How would you briefly describe the nature of a thoracoabdominal aortic aneurysm (TAAA) and how it differs from everyday cases? How does this affect the options that treating physicians have at their disposal?
The classic definition of a TAAA is an aneurysm that spans both the thoracic and abdominal cavities. I think with endovascular options evolving, this definition is coming into question and may be based more on limits of required aortic coverage…..
Source: Endovascular TODAY